Skip to search formSkip to main contentSkip to account menu

crasnitin activity

Known as: crasnitin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The enzyme L-asparaginase is an important component of the treatment protocols for Acute Lymphoblastic Leukemia (ALL). This… 
1997
1997
Asparaginase (ASE) preparations from two biological sources (Escherichia coli and Erwinia caratovora) and companies are in… 
1997
1997
Asparaginase preparations from different biological sources and companies are in clinical use. In the event of adverse reactions… 
1977
1977
The immune response of CBA-mice against alum adsorbed BGG is depressed by daily injections of 20, 40 and 80 I.U. of asparaginase… 
1976
1976
The influence of L-asparaginase (Crasnitin) on cellular reactions in the course of immunologically specific and nonspecific… 
1970
1970
  • U. FinkH. Begemann
  • 1970
  • Corpus ID: 35136950
An immunosuppressive effect of L-asparaginase seems to be likely. Therefore it is interesting to investigate the effect of L… 
1970
1970
Crasnitin 1 (L-asparaginase) is a new therapeutic agent in the treatment of acute lymphoblastic leukemia. In the development of… 
1970
1970
This report is concerned with light microscopic and, especially, electron microscopic changes taking place under the influence of… 
1970
1970
  • R. Bierling
  • 1970
  • Corpus ID: 12293877
In 1968 sufficient L-asparaginase (Crasnitin)1 became available from our own production to start clinical trials. At this time we…